Utilizing Engineered E. Coli as An Asymmetric Biocatalyst towards Pharmaceutical Precursors

Brent D. Feske

Utilizing Engineered E. Coli as An Asymmetric Biocatalyst towards Pharmaceutical Precursors

Brent D. Feske

Biochemistry, Chemistry & Physics

Research output: Contribution to conference › Presentation

Abstract

This presentation was given at SERMACS.

Original language	American English
State	Published - Jan 1 2009
Event	SERMACS - Nashville, TN Duration: Oct 17 2014 → …

Conference

Conference	SERMACS
Period	10/17/14 → …

Disciplines

Chemistry

Keywords

Asymmetric biocatalyst
Engineered E. Coli
Pharmaceutical precursors
Utilizing

Cite this

@conference{6402555a81f04efc866ad00c1c57e7cf,

title = "Utilizing Engineered E. Coli as An Asymmetric Biocatalyst towards Pharmaceutical Precursors",

abstract = " This presentation was given at SERMACS.",

keywords = "Asymmetric biocatalyst, Engineered E. Coli, Pharmaceutical precursors, Utilizing",

author = "Feske, {Brent D.}",

year = "2009",

month = jan,

day = "1",

language = "American English",

note = "SERMACS ; Conference date: 17-10-2014",

}

TY - CONF

T1 - Utilizing Engineered E. Coli as An Asymmetric Biocatalyst towards Pharmaceutical Precursors

AU - Feske, Brent D.

PY - 2009/1/1

Y1 - 2009/1/1

N2 - This presentation was given at SERMACS.

AB - This presentation was given at SERMACS.

KW - Asymmetric biocatalyst

KW - Engineered E. Coli

KW - Pharmaceutical precursors

KW - Utilizing

UR - https://digitalcommons.georgiasouthern.edu/chem-facpres/237

M3 - Presentation

T2 - SERMACS

Y2 - 17 October 2014

ER -

Utilizing Engineered E. Coli as An Asymmetric Biocatalyst towards Pharmaceutical Precursors

Abstract

Conference

Disciplines

Keywords

Other files and links

Fingerprint

Cite this